Orange Kenya’s Mpedigree to Fight Counterfeit Drugs
The Mpedigree system will be rolled out across various health centers in Kenya, utilizing the unique serial numbers of each drug. By comparing these serial numbers with genuine ones, any discrepancies will raise concerns about the drug's authenticity. Serial numbers will be scanned before any drug is prescribed to patients, effectively eliminating the risk of counterfeit drugs. During the launch, Kenya's Minister of Medical Services, Prof. Anyang Nyongo, emphasized the importance of being vigilant in fighting the manufacturing of fake drugs by cracking down on the companies responsible. Orange Kenya's CEO, Mickael Ghossein, expressed the company's commitment to eradicating counterfeit drugs in the country. He also highlighted that the launch of Mpedigree was part of Orange's broader efforts to remain a leading provider of e-solutions that cater to market needs while offering convenience to customers.
While the announcement of Mpedigree's integration into Orange's operations in Africa was made earlier this year, its implementation comes two months after the Kenyan government unveiled its e-health strategy. Orange Kenya aims to leverage its fast 3G internet connection platform, with speeds of up to 21Mbps, in collaboration with other partners to establish potential ICT solutions that will benefit its customers. In this context, Mpedigree will enhance the government's initiatives to deliver quality medical care as outlined in the new constitution. Orange has also formed partnerships with renowned industry players such as Qualcomm as part of the "Wireless Reach" project, which focuses on automating the procurement of antiretroviral drugs at public clinics.
What date was this posted? This could be a very useful initiative – I think the technology was developed in Ghana
ReplyDelete